share_log

Clover Health Investments And 2 Other Stocks Under $1 Insiders Are Buying

Clover Health Investments And 2 Other Stocks Under $1 Insiders Are Buying

Clover Health Investments和其他2只低於1美元的股票內部人士正在買入
Benzinga ·  05/21 20:40

The Dow Jones index closed lower by 0.5% on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道瓊斯指數週一收盤下跌0.5%。當內部人士購買或出售股票時,這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將此視爲他們整體投資或交易決策的一個因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是細價股最近幾筆值得注意的內幕交易。欲了解更多信息,請訪問Benzinga的內幕交易平台。

MultiPlan

多套餐

  • The Trade: MultiPlan Corporation (NYSE:MPLN) Director Anthony Colaluca Jr bought a total of 160,000 shares at an average price of $0.60. To acquire these shares, it cost around $96,000.
  • What's Happening: On May 8, MultiPlan posted a GAAP loss of 83 cents per share.
  • What MultiPlan Does: MultiPlan Corp is a provider of data analytics and technology-enabled solutions designed to bring affordability, efficiency, and fairness to the U.S. healthcare industry.
  • 貿易:MultiPlan Corporation(紐約證券交易所代碼:MPLN)董事小安東尼·科拉盧卡以0.60美元的平均價格共購買了16萬股股票。收購這些股票的成本約爲96,000美元。
  • 發生了什麼:5月8日,MultiPlan公佈的每股GAAP虧損爲83美分。
  • MultiPlan的作用:MultiPlan Corp是一家數據分析和技術解決方案的提供商,旨在爲美國醫療保健行業帶來可負擔性、效率和公平性。

Fresh Tracks Therapeutics

新曲目療法

  • The Trade: Fresh Tracks Therapeutics, Inc. (OTC:FRTX) 10% owner Exploration Capital, LLC acquired a total of 74,565 shares at an average price of $0.92. To acquire these shares, it cost around $68,592.
  • What's Happening: The company's stock gained around 16% over the past six months.
  • 交易:Fresh Tracks Therapeutics, Inc.(場外交易代碼:FRTX)10%的所有者Exploration Capital, LLC共收購了74,565股股票,平均價格爲0.92美元。收購這些股票的成本約爲68,592美元。
  • 發生了什麼:該公司的股票在過去六個月中上漲了約16%。

Clover Health Investments

三葉草健康投資

  • The Trade: Clover Health Investments, Corp. (NASDAQ:CLOV) Director Anna U Loengard acquired a total of 27,085 shares at an average price of $0.94. The insider spent around $25,672 to buy those shares.
  • What's Happening: On May 7, Clover Health Investments reported better than expected first-quarter financial results.
  • What Clover Health Investments Does: Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant.
  • 交易:三葉草健康投資公司(納斯達克股票代碼:CLOV)董事安娜·羅恩加德共收購了27,085股股票,平均價格爲0.94美元。知情人士花費了約25,672美元購買了這些股票。
  • 發生了什麼:5月7日,三葉草健康投資公佈的第一季度財務業績好於預期。
  • 三葉草健康投資的所作所爲:三葉草健康投資公司是一家醫療保健技術公司。它專注於通過其專有軟件平台Clover Assistant使醫療保險醫生能夠主動管理慢性病。

Read More: Jim Cramer Says This Materials Stock Is A 'Great Spec,' Plus He Recommends Buying Abercrombie & Fitch

閱讀更多:吉姆·克萊默說這種材料股是 “很好的規格”,而且他建議買入Abercrombie & Fitch

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論